CTRI/2018/07/015116Other不适用
A blood test to determine the probability of developing cancer and/ or its stage, by analysing theexpression profile of molecular immuno-markers in healthy and cancer patients.
试验速览
- 阶段
- 不适用
- 状态
- Other
- 入组人数
- 1,000
- 试验地点
- 1
- 主要终点
- The expression profile of the molecular immuno-
研究概览
简要总结
The study was terminated because the protocol required some modification. Total of 24 participants were enrolled in this study.
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 21.00 Year(s) 至 85.00 Year(s)（—）
- 性别
- All
入选标准
- •Cancer group.
- •Have a type of cancer disease.
- •Healthy group.
- •who are not on any regular medication.
- •Are aged 21 years or older.
- •Are willing to consent to the storage of specimens for future research.
- •Subjects enrolled will be able to provide informed consent for themselves.
排除标准
- •Are incarcerated.
- •2 Are unwilling or unable to comply with prescribed therapy.
- •Subjects that lack the capacity to provide informed consent autonomously are to be excluded.
- •Pregnant or lactating women.
- •Subjects who have participated in any clinical trial in the past 1 month.
- •Any other condition that in the opinion of the investigator that does not justify the subject’s participation in the trial.
结局指标
主要结局
The expression profile of the molecular immuno-
时间窗: 0 days
markers will help in analyzing the probability of manifestation of cancer, before any clinical
时间窗: 0 days
symptoms begin to appear in healthy individuals and the development of the disease in
时间窗: 0 days
cancer patients.
时间窗: 0 days
次要结局
- The expression profile of the molecular immuno-(markers will help in understanding the efficacious treatment for the cancer patient)
研究者
研究点 (1)
Loading locations...
相似试验
已完成
不适用
Prospective combined analysis of spirometry, impulse oscillation, and chest tomography for the effect of salmeterol/fluticasone (SFC) in COPDChronic Obstructive Pulmonary Disease (COPD)JPRN-UMIN000004097agoya University Graduate School of Medicine34
Unknown
不适用
A randomized, double-blind, Placebo-controlled, three arms, parallel-group, multiple-site bioequivalence study with clinical endpointsCTRI/2018/11/016407Encube Ethicals Private Ltd501
终止
1 期
Atacicept in Lupus Nephritis Patients Taking Stable Regimen of Mycophenolate MofetilLupus NephritisNCT01369628EMD Serono1
已完成
不适用
Evaluation of microsampling systems for bloodanalysis in the follow-up of patientsdiagnostiekPreanalytical procudures for bloodsamplingNL-OMON49860Medlon b.v. Medische Diagnostiek80
已完成
不适用
Investigation of the optimum rate of patient controlled epidural analgesia after cesarean sectioCesarean sectionJPRN-UMIN000009939Asahikawa Medical University27